Immunomodulatory therapy for the management of severe COVID-19. Beyond the anti-viral therapy: A comprehensive review
J Alijotas-Reig, E Esteve-Valverde, C Belizna… - Autoimmunity …, 2020 - Elsevier
Abstract Severe Acute Respiratory Syndrome related to Coronavirus-2 (SARS-CoV-2),
coronavirus disease-2019 (COVID-19) may cause severe illness in 20% of patients. This …
coronavirus disease-2019 (COVID-19) may cause severe illness in 20% of patients. This …
[HTML][HTML] Immunomodulatory therapy for the management of severe COVID-19. Beyond the anti-viral therapy: A comprehensive review
J Alijotas-Reig, E Esteve-Valverde, C Belizna… - Autoimmunity …, 2020 - ncbi.nlm.nih.gov
Abstract Severe Acute Respiratory Syndrome related to Coronavirus-2 (SARS-CoV-2),
coronavirus disease-2019 (COVID-19) may cause severe illness in 20% of patients. This …
coronavirus disease-2019 (COVID-19) may cause severe illness in 20% of patients. This …
[PDF][PDF] Immunomodulatory therapy for the management of severe COVID-19. Beyond the anti-viral therapy: A comprehensive review
J Alijotas-Reig, E Esteve-Valverde… - Autoimmunity …, 2020 - umfcs.u-bordeaux.fr
ABSTRACT Severe Acute Respiratory Syndrome related to Coronavirus-2 (SARS-CoV-2),
coronavirus disease-2019 (COVID-19) may cause severe illness in 20% of patients. This …
coronavirus disease-2019 (COVID-19) may cause severe illness in 20% of patients. This …
Immunomodulatory therapy for the management of severe COVID-19. Beyond the anti-viral therapy: A comprehensive review
J Alijotas-Reig, E Esteve-Valverde… - Autoimmunity …, 2020 - pubmed.ncbi.nlm.nih.gov
Severe Acute Respiratory Syndrome related to Coronavirus-2 (SARS-CoV-2), coronavirus
disease-2019 (COVID-19) may cause severe illness in 20% of patients. This may be in part …
disease-2019 (COVID-19) may cause severe illness in 20% of patients. This may be in part …
Immunomodulatory therapy for the management of severe COVID-19. Beyond the anti-viral therapy: A comprehensive review
J Alijotas-Reig, E Esteve-Valverde… - Autoimmunity …, 2020 - portalrecerca.uab.cat
Abstract Severe Acute Respiratory Syndrome related to Coronavirus-2 (SARS-CoV-2),
coronavirus disease-2019 (COVID-19) may cause severe illness in 20% of patients. This …
coronavirus disease-2019 (COVID-19) may cause severe illness in 20% of patients. This …
Immunomodulatory therapy for the management of severe COVID-19. Beyond the anti-viral therapy: A comprehensive review
J Alijotas-Reig, E Esteve-Valverde, C Belizna… - Autoimmunity …, 2020 - Elsevier
Abstract Severe Acute Respiratory Syndrome related to Coronavirus-2 (SARS-CoV-2),
coronavirus disease-2019 (COVID-19) may cause severe illness in 20% of patients. This …
coronavirus disease-2019 (COVID-19) may cause severe illness in 20% of patients. This …
Immunomodulatory therapy for the management of severe COVID-19. Beyond the anti-viral therapy: A comprehensive review.
J Alijotas-Reig, E Esteve-Valverde, C Belizna… - Autoimmunity …, 2020 - europepmc.org
Abstract Severe Acute Respiratory Syndrome related to Coronavirus-2 (SARS-CoV-2),
coronavirus disease-2019 (COVID-19) may cause severe illness in 20% of patients. This …
coronavirus disease-2019 (COVID-19) may cause severe illness in 20% of patients. This …
Immunomodulatory therapy for the management of severe COVID-19. Beyond the anti-viral therapy: A comprehensive review.
J Alijotas-Reig, E Esteve-Valverde, C Belizna… - Autoimmunity …, 2020 - europepmc.org
Abstract Severe Acute Respiratory Syndrome related to Coronavirus-2 (SARS-CoV-2),
coronavirus disease-2019 (COVID-19) may cause severe illness in 20% of patients. This …
coronavirus disease-2019 (COVID-19) may cause severe illness in 20% of patients. This …